
The journal “Real-world data & evidence” aims to publish original research and reviews on the use of real-world data (RWD) to assess treatment outcomes and make health decisions.
Articles published in the journal “Real-world data & evidence” cover, but are not limited, key research areas, such as registers, medical databases, electronic medical records, drug use and outcomes in routine medical practice, drugs prescription, drugs safety, adherence, comparative effectiveness research, pharmacoeconomics and outcomes research, including the cost-of-illness analysis, pragmatic clinical trials, exploring research methodology based on RWD, including collecting, tracking, searching, sharing, analyzing and interpreting Big Data.
Also, the journal website www.MyRWD.ru published news about the research carried out in real-world clinical practice, and conferences, congresses and other events announcements.
The journal "Real-world data & evidence" - it is a system of online publications: after the completion of the work on the manuscript, it published on the journal's website as soon as possible with the assignment of a DOI. Once published online, no changes can be made to the manuscript. Every three months, all manuscripts published during this period on the site, combined into a current issue. Before the release of the current issue of the journal, authors can print the articles published on the site, which will contain the necessary output data.
Current issue
ACTUAL REVIEW 
REGULATORY SYSTEM 
DRUG SAFETY 
SOFTWARE 
MARKET 
News
2022-07-13
Experts of Raevsky clinics: oncopsychology is necessary in cancer treatment
![]() | On June 30, 2022, an online conference "Treatment of oncology with integrative methods" was held as part of the All-Russian Scientific and Educational Project. It was conducted by the staff of Dmitry Raevsky's network of integrative medicine clinics. They spoke about the need to include oncopsychology in the complex treatment of oncological diseases. |
2022-07-01
Moscow hosted the 9th annual conference "Health Technology Assessment", dedicated to improving the drug supply strategy
![]() | In the new economic conditions, the issue of increasing the efficiency of organizing and financing the healthcare system to ensure the quality and accessibility of medical care both at the federal and regional levels is extremely acute. |
2022-06-02
Results of the V Annual All-Russian Scientific and Practical Conference with International Participation "Safety of Pharmacotherapy: Noli nocere!"
![]() | On May 19, 2022, the V Annual All-Russian Scientific and Practical Conference with international participation “Safety of Pharmacotherapy: Noli nocere!” was held at the RMANPE, which was held as part of the XIII All-Russian Meeting “Actual Issues of Clinical Pharmacology and Drug Supply”. |
2022-06-01
IX INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE "HEALTH TECHNOLOGY ASSESSMENT: IMPROVING THE DRUG SUPPLY DEVELOPMENT STRATEGY"
![]() | On June 21-22, 2022, Moscow will host the IX International Scientific and Practical Conference "Health Technology Assessment: Improving the Strategy for the Development of the Drug Supply System". |
2022-05-19
Innovative doctors at a free conference will talk about psychotherapy in the treatment of oncology
![]() | The free online conference "Psychotherapy in Oncology" will be held on May 26. |
2022-04-27
Russian Pharmaceutical Forum named after Semashko: the main meeting place for the pharmaceutical market acquires a new name
![]() | The Russian Pharmaceutical Forum has been the main platform for meeting the entire Russian pharmaceutical market and discussing the most pressing and pressing issues of the pharmaceutical industry for 28 years. The rich history of the Forum and the challenges that the national drug supply system is currently facing turned the attention of the Forum organizers to the historical experience of building and forming a unique model of the national healthcare system built by the outstanding healthcare organizer Nikolai Semashko. |
2022-04-15
Overuse of short-acting beta-2-agonists in bronchial asthma in Russia
![]() | The international scientific journal Journal of Asthma and Allergy published an article "SABA abuse in Russia - burden and possible causes: analysis of the Russian population included in the SABINA III study", which highlights the results of a study of real clinical practice of Russian patients with bronchial asthma (BA), receiving therapy with SABA (short-acting beta-2-agonists). The study showed that in Russia there is a high level of excessive prescription of SABA, which may be correlated with the problem of inadequate control of the course of bronchial asthma and the occurrence of frequent severe exacerbations. The frequency of SABA overuse was not associated with disease severity. |
2022-04-15
A systematic review of real-world clinical practice data in COVID-19: non-interventional studies
![]() | As defined by the Food and Drug Administration, real-world data (RWD) is data related to a patient's health and/or health care delivery, usually collected from various sources as part of real-world clinical practice research. |
2022-04-14
CONFERENCE “REAL-WORLD DATA IN A CHANGING WORLD. CHALLENGES AND SOLUTIONS” IN SEPTEMBER 2022
![]() | The Association of Specialists in the Field of Health Technology Assessment, the Association of Clinical Pharmacologists, the St. Petersburg Division of the International Society for Pharmacoeconomic Research and Scientific Analysis - ISPOR express their deep respect and invite you to accept participation in the work of the III annual scientific and practical RWD / RWE conference: “Real-world data in a changing world. Challenges and Solutions”, which will take place in September 2022, on September 15 or 22. |
2022-04-12
On April 18-19, the conference "Actual issues of preclinical and clinical trials of drugs and clinical trials of medical devices" will be held
![]() | First St. Petersburg State Medical University named after Academician I.P. Pavlov invites you to take part in the IX All-Russian Conference with international participation "Actual issues of preclinical and clinical trials of drugs, biomedical cell products and clinical trials of medical devices", which will be held in St. Petersburg on April 18 and 19, 2022. |
More News... |